|
ARNTL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.65450000039402E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96190000001373E-06 |
| Normal-vs-Stage2 |
6.511200E-01 |
| Normal-vs-Stage3 |
1.84151000000021E-05 |
| Normal-vs-Stage4 |
4.030500E-04 |
| Stage1-vs-Stage2 |
1.596450E-04 |
| Stage1-vs-Stage3 |
2.378800E-01 |
| Stage1-vs-Stage4 |
4.087800E-01 |
| Stage2-vs-Stage3 |
1.425610E-04 |
| Stage2-vs-Stage4 |
1.622510E-03 |
| Stage3-vs-Stage4 |
8.675400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48589999696236E-08 |
| Normal-vs-AfricanAmerican |
3.631900E-02 |
| Normal-vs-Asian |
6.439900E-03 |
| Caucasian-vs-AfricanAmerican |
7.601800E-01 |
| Caucasian-vs-Asian |
1.374000E-01 |
| AfricanAmerican-vs-Asian |
3.908600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.633600E-04 |
| Normal-vs-Female |
3.23900000043231E-07 |
| Male-vs-Female |
4.844600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.42710000051017E-07 |
| Normal-vs-Age(41-60Yrs) |
2.382900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.280500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.846000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.658100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.116400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.826000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.818600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.025800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.793800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.019700E-02 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
5.509600E-02 |
| Classical-VS-Normal |
3.00129998631604E-09 |
| Tall-VS-Follicular |
3.99910000000725E-05 |
| Tall-VS-Other |
5.141900E-03 |
| Tall-VS-Normal |
1.951550E-04 |
| Follicular-VS-Other |
1.237520E-02 |
| Follicular-VS-Normal |
1.557620E-01 |
| Other-VS-Normal |
2.777400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.216800E-03 |
| Normal-vs-N1 |
6.3959999999974E-05 |
| N0-vs-N1 |
2.875600E-02 |
|
|
